Article thumbnail

Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures

By Carlos E. Caicedo-Carvajal, Qing Liu, Yvonne Remache, Andre Goy and K. Stephen Suh

Abstract

Isolation and amplification of primary lymphoma cells in vitro setting is technically and biologically challenging task. To optimize culture environment and mimic in vivo conditions, lymphoma cell lines were used as a test case and were grown in 3-dimension (3D) using a novel 3D tissue culture polystyrene scaffold with neonatal stromal cells to represent a lymphoma microenvironment. In this model, the cell proliferation was enhanced more than 200-fold or 20,000% neoplastic surplus in 7 days when less than 1% lymphoma cells were cocultured with 100-fold excess of neonatal stroma cells, representing 3.2-fold higher proliferative rate than 2D coculture model. The lymphoma cells grew and aggregated to form clusters during 3D coculture and did not maintained the parental phenotype to grow in single-cell suspension. The cluster size was over 5-fold bigger in the 3D coculture by day 4 than 2D coculture system and contained less than 0.00001% of neonatal fibroblast trace. This preliminary data indicate that novel 3D scaffold geometry and coculturing environment can be customized to amplify primary cancer cells from blood or tissues related to hematological cancer and subsequently used for personalized drug screening procedures

Topics: Research Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier: oai:pubmedcentral.nih.gov:3168765
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). 3-D tumor model for in vitro evaluation of anticancer drugs,”
  2. 3D tumour models: novel in vitro approaches to cancer studies,”
  3. (2009). A .V .K u r t o v a ,A .T .T a m a y o ,R .J .F o r d ,a n dJ .A .B u r g e r , “Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting,”
  4. (2010). Activation of fibroblasts in cancer stroma,”ExperimentalCellResearch,vol.316,no.17,pp.2713– 2722,
  5. (2008). Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFβ/BMP-6 and TIEG1 in chemotherapy escape,”
  6. (2007). Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB
  7. (2008). Bortezomib in mantle cell lymphoma,”
  8. (2005). characterization of multipotent skin-derived precursors from human skin,”
  9. (2009). Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma,” MAbs,
  10. (2002). Development: stromal effects on mammary gland development and breast cancer,”
  11. (2011). Drug resistance: challenges to effective therapy,”
  12. (2010). Engineered polystirene scaffolds for in vitro three-dimensional diesease models,”
  13. (2007). Engineering tumors with 3D scaffolds,”
  14. (2007). Expanding therapeutic options in mantle cell lymphoma,”
  15. (2001). F o r t n e y ,W .Z h a o
  16. (2010). Fernandez DeMattos,andF.Cabanillas,“Therapeuticconceptsinmantle cell lymphoma,”
  17. (2010). Florczyk et al., “Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance,”
  18. (2006). Four human t(11;14)(q13;q32)-containingcelllineshavingclassicandvariant features
  19. (2010). Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts,”
  20. (2009). Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells,”
  21. (2009). i ,G .W a n g ,Z .L i u ,Z .F e n g ,B .H u a n g ,a n dX .Z h a o , “Influence of a self-assembling peptide, RADA16, compared with collagen I and matrigel on the malignant phenotype of human breast-cancer cells in 3D cultures and in vivo,”
  22. Implications of the tumor microenvironment on survival and disease response in follicular lymphoma,” CurrentOpinioninOncology,vol.22,no.5,pp.424–430,2010.
  23. (2005). Isolation and culture of skin fibroblasts,”
  24. (1986). Long-term culture of infant leukemia cells: dependence upon stromal cells from the bone marrow and bilineage differentiation,”
  25. (2011). Lymph node stroma broaden the peripheral tolerance paradigm,”
  26. (2008). Lymphoma microenvironment: culprit or innocent?”
  27. (2007). Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis,”
  28. (2000). Mantle cell lymphoma proliferates upon
  29. Mantle cell lymphoma,”
  30. (2006). More than structural cells, fibroblasts create and orchestrate the tumor microenvironment,”
  31. (2011). Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells,”
  32. (2010). N.Li,M.Fukunaga-Kalabis,H.Yuetal.,“Humandermalstem cells differentiate into functional epidermal melanocytes,”
  33. (2006). Primate embryonic stem cells create their own niche while differentiating
  34. (2003). Prostate development and carcinogenesis,”
  35. (2005). r o w s e ,L .R .M c Q u a d e ,K .J .B r y a n t ,D .D .V a n
  36. (2001). Reactive stroma in prostate cancer progression,”
  37. (2000). Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures,”
  38. (2003). Spatial organization of three-dimensional cocultures of adriamycin-sensitive and -resistanthumanbreastcancerMCF-7cells,”BiologyoftheCell,
  39. (2011). Stromal endothelial cells directly influence cancer progression,”
  40. (2010). The microenvironment determines the breast cancer cells’ phenotype: organization of MCF7 cells in 3D cultures,”
  41. (2010). The normal microenvironment directs mammary gland development,”
  42. (2005). Threedimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen,”
  43. (2010). Tissueengineered three-dimensional tumor models to study tumor angiogenesis,” Tissue Engineering Part A,v o l .1 6 ,n o .7 ,p p .
  44. (2011). Toward modeling the bone marrow niche using scaffold-based 3D culture systems,”
  45. (2010). u r d e t t ,F .K .K a s p e r ,A .G .M i k o s ,a n dJ .A .L u d w i g , “Engineering tumors: a tissue engineering perspective in cancer biology,” Tissue Engineering Part B,v o l .1 6 ,n o .3 ,p p .
  46. (2007). Zirlik et al., “Essential role of stromally induced hedgehog signaling in